1Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 2001, 345(10):725-730.
2Kim S, Lim DH, Lee J, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys, 2005,63(5):1279-1285.
3Milano MT, Garofalo MC, Chmura SJ, et al. Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques. Br J Radiol, 2006, 79(942):497-503.
5International Commission on Radiation Units and Measurements. ICRU Report 50: Prescribing, recording and reporting photon beam therapy. Washington, D.C.: ICRU,1993.
6Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol, 2003, 13(3):176-181.
7Park SH, Kim DY, Heo JS, et al. Postoperative chemoradiotherapy for gastric cancer. Ann Oncol,2003,14(9):1373-1377.
8Hughes BG, Yip D, Chao M, et al. Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience. ANZ J Surg, 2004,74(11):951-956.
9Leong CN, Chung HT, Lee KM, et al. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma. Cancer J,2008,14(4):269-275.
10Leong T, Willis D, Joon DL, et al. 3D conformal radiotherapy for gastric cancer results of a comparative planning study. Radiother Oncol, 2005, 74 (3):301-306.
